1Hosenpud JD, Bennnett LE, Keck BM, et al. The registry of the international society for heart and lung transplantation: eighteenth official report. J Heart Lung Transplant, 2001,20: 805-816.
2Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection:lung rejection study group. J Heart Lung Transplant, 1996,15:1-15.
3Schulman LL, Weinberg AD, McGregor C, et al. Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation. Am J Respir Crit Care Med, 1998,157:1833-1837.
4Gotway MB, Dawn SK, Sellami D, et al. Acute rejection following lung transplantation: limitation in accuracy of thin-section CT for diagnosis. Radiology, 2001,221:207-212.
6Chaparro C, Maurer JR, Chamberlain DW, et al. Role of open lung biopsy for diagnosis in lung transplant recipients: ten-year experience,Ann Thorac Surg, 1995, 59:928-932.
7Weill D,Mcgiffin DC,Zorn GL,et al. The utility of open lung biopsy following lung transplantation. J Heart Lung Transplant, 2000,19:852-857.
8Wager FM, Jamieson SW, Fung J, et al. A new concept for successful long term pulmonary preservation in a dog model. Transplantation, 1995,59: 153.
9Lin PJ, Hsieh M J, Chen KS, et al. University of Wisconsin solution extends lung preservation after prostaglandin E 1 infusion. Chest, 1994,105(1): 255.
10Chiang CH,Wu K,Yu CP,et al. Protective agents used as additives in University of Wisconsin solution to promote protection against ischaemia- reperfusion injury in rat lung. Clin Sci (Colch), 1998,95(3): 369.
